edoc

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

Vermersch, P. and Kappos, L. and Gold, R. and Foley, J. F. and Olsson, T. and Cadavid, D. and Bozic, C. and Richman, S.. (2011) Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology, Vol. 76, H. 20. pp. 1697-1704.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6006990

Downloads: Statistics Overview

Abstract

Natalizumab, a therapy for multiple sclerosis (MS), has been associated with progressive multifocal leukoencephalopathy (PML), a rare opportunistic infection of the CNS associated with the JC virus. We assessed clinical outcomes and identified variables associated with survival in 35 patients with natalizumab-associated PML.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
UniBasel Contributors:Kappos, Ludwig
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Lancet Publications
ISSN:0028-3878
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:06 Dec 2013 09:36
Deposited On:06 Dec 2013 09:36

Repository Staff Only: item control page